About Recovia
Services
Type of Care
Substance use treatment; Detoxification; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient detoxification; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine detoxification; Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders
Treatment Approaches
Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Trauma-related counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State department of health
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid
Special Programs/Groups Offered
Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders; Clients who have experienced trauma
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Mentoring/peer support
Detoxification (medical withdrawal) Services
Opioids detoxification; Medication routinely used during detoxification
Education and Counseling Services
Substance use disorder education; Individual counseling; Group counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Mental health services; Social skills development
Type of Care
Substance use treatment; Detoxification; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient detoxification; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine detoxification; Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders
Treatment Approaches
Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Trauma-related counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State department of health
Payment/Insurance/Funding Accepted
Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid
Special Programs/Groups Offered
Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders; Clients who have experienced trauma
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Mentoring/peer support
Detoxification (medical withdrawal) Services
Opioids detoxification; Medication routinely used during detoxification
Education and Counseling Services
Substance use disorder education; Individual counseling; Group counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Mental health services; Social skills development
